Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Ishara Investments LP
Form 13F · Q2 2026

Ishara Investments LP

CIK 2111609申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$1.4亿
申報組合市值
41
持倉數量
3
Quarters on record
Top 50
持倉數量

Ishara Investments LP——持倉

共 41 個持倉中的前 41 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1ACAD Acadia Pharmaceuticals Inc410,000+233.3%$1037万7.6%
2XERS Xeris Biopharma Holdings Inc1.2M+20.0%$974万7.2%
3BMRN Biomarin Pharmaceutical Inc143,500+75.0%$821万6.0%
4PRAX Praxis Precision Medicines I22,550+0.0%$755万5.5%
5RARE Ultragenyx Pharmaceutical In205,000+17.6%$684万5.0%
6AGIO Agios Pharmaceuticals Inc164,000—$609万4.5%
7INSM Insmed Inc51,250—$546万4.0%
8CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In143,500—$537万3.9%
9ZNTL Zentalis Pharmaceuticals Inc1.0M−16.7%$497万3.7%
10PCVX Vaxcyte Inc82,000+42.9%$477万3.5%
11ANNX Annexon Inc820,000+370.6%$468万3.4%
12TVTX Travere Therapeutics Inc82,000−25.9%$466万3.4%
13TNXP Tonix Pharmaceuticals Hldg C338,250—$432万3.2%
14BBIO Bridgebio Pharma Inc57,400—$428万3.1%
15AXSM Axsome Therapeutics Inc.16,400−60.0%$401万2.9%
16CTNM Contineum Therapeutics Inc205,000+44.4%$336万2.5%
17LXRX Lexicon Pharmaceuticals Inc1.3M+40.9%$305万2.2%
18KURA Kura Oncology Inc276,750—$304万2.2%
19DBVT Dbv Technologies S A184,500+80.0%$303万2.2%
20GMAB Genmab A/S102,500+25.0%$282万2.1%
21CYTK Cytokinetics Inc32,800—$279万2.1%
22MLYS Mineralys Therapeutics Inc102,500+25.0%$277万2.0%
23SLN Silence Therapeutics Plc55,350−60.6%$243万1.8%
24NUVB Nuvation Bio Inc369,000—$210万1.5%
25WVE Wave Life Sciences Ltd328,000—$191万1.4%
26NKTR Nektar Therapeutics26,650—$186万1.4%
27SRRK Scholar Rock Hldg Corp30,750−46.4%$169万1.2%
28ELVN Enliven Therapeutics Inc32,800—$166万1.2%
29ALNY Alnylam Pharmaceuticals Inc5,125+0.0%$154万1.1%
30BEAM Beam Therapeutics Inc41,000−28.6%$141万1.0%
31SION Sionna Therapeutics Inc123,000+150.0%$135万1.0%
32ORIC Oric Pharmaceuticals Inc123,000+20.0%$133万1.0%
33NAMS Newamsterdam Pharma Company36,900+0.0%$125万0.9%
34VRTX Vertex Pharmaceuticals Inc2,460—$122万0.9%
35SPRY Ars Pharmaceuticals Inc143,490—$115万0.8%
36MNPR Monopar Therapeutics Inc12,300—$114万0.8%
37ERAS Erasca Inc41,000—$75万0.6%
38VERA Vera Therapeutics Inc10,250−87.5%$44万0.3%
39IMTX Immatics N.V30,750−80.0%$31万0.2%
40MREO Mereo Biopharma Group Plc768,750—$24万0.2%
41GOSS Gossamer Bio Inc820,000+0.0%$13万0.1%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。